Diagnostic value of high-risk HPV other than type 16/18 in high-grade cervical neoplasia among cytology-negative women: A multicenter retrospective study

被引:8
|
作者
Bai, Anying [1 ]
Xue, Peng [1 ,3 ]
Li, Qing [2 ]
Jiang, Yu [1 ,3 ]
Qiao, Youlin [1 ]
机构
[1] Chinese Acad Med Sci & Peking Union Med Coll, Sch Populat Med & Publ Hlth, Dept Epidemiol & Biostat, Beijing, Peoples R China
[2] Shenzhen Matern & Child Healthcare Hosp, Diag & Treatment Cerv Les Ctr, Shenzhen, Peoples R China
[3] Chinese Acad Med Sci & Peking Union Med Coll, Sch Populat Med & Publ Hlth, Dept Epidemiol & Biostat, Beijing 100730, Peoples R China
来源
CANCER MEDICINE | 2023年 / 12卷 / 13期
关键词
cervical cancer; cytology; HPV genotype; unnecessary referrals; PATHOLOGY SCREENING GUIDELINES; AMERICAN-CANCER-SOCIETY; HUMAN-PAPILLOMAVIRUS; INTRAEPITHELIAL NEOPLASIA; POSITIVE WOMEN; INFECTIONS; PREVENTION; TRIAGE; PREVALENCE; COLPOSCOPY;
D O I
10.1002/cam4.6109
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Human papillomavirus (HPV) is a necessary cause of cervical cancer, and a tool more sensitive than cytology for the early screening of cervical precancers. The two most carcinogenic genotypes HPV 16/18 have been reported in the majority of studies. High-risk HPVs other than HPV 16/18 (non-16/18-hrHPVs) cause approximately a quarter of cervical cancers, and we aimed to analyze the genotype-specific prevalence, risk and diagnostic efficiency of non-16/18-hrHPVs in cervical carcinogenesis among Chinese cytology-negative women.Methods: A total of 7043 females who had abnormal cervical testing results from January 2018 to October 2021 were enrolled, among them 3091 were cytology-negative. Descriptive statistics was used to estimate the HPV genotype-specific prevalence, and multivariable logistic regression was used to estimate the genotype-specific non-16/18 hrHPVs risk of cervical carcinogenesis. The evaluation of diagnostic value among HPV genotypes included the possibility of predicting cervical intraepithelial neoplasia grade 2/3 or worse (CIN2+/CIN3+) and the diagnostic efficiency measured by increased referral rate and referral numbers of colposcopies per additional CIN2+/CIN3+ detected.Results: Among HPV-positive cytology-negative women, the five dominant genotypes for CIN2+/CIN3+ were HPV 31/33/35/52/58. HPV 52/58/33 had comparatively high sensitivity and specificity in predicting CIN2+/CIN3+, while the referral strategy of multiple HPV58 required 26 colposcopies to detect 1 CIN3+, compared with 14, 12, and 8 required by multiple HPV52, 31, and 33, respectively.Conclusions: HPV31/33/35/52/58 infections are significant risk factors for cervical lesions, and multiple HPV 31/33/52 infections should be included in the previously recommended HPV16/18 genotyping triage for colposcopy in China, as the benefits of disease prevention may outweigh the disadvantages of increasing requirements for colposcopy services.
引用
下载
收藏
页码:14794 / 14805
页数:12
相关论文
共 50 条
  • [1] Immediate risk of cervical intraepithelial neoplasia and diagnostic value of colposcopy among cytology-negative women with oncogenic HPV: a retrospective study
    Dai, Weichao
    Wang, Tongfei
    Chen, Lin
    Qiu, Zhongyuan
    Chen, Peifang
    Chen, Dezhao
    BMC WOMENS HEALTH, 2024, 24 (01)
  • [2] Prevalence of high-grade cervical intraepithelial neoplasia in women with persistent high-risk HPV genotypes and negative cytology
    Macdonald, M.
    Crossley, J.
    Ellis, K.
    Dudding, N.
    Lyon, R.
    Smith, J. H. F.
    Tidy, J. A.
    Palmer, J. E.
    CYTOPATHOLOGY, 2018, 29 (02) : 133 - 142
  • [3] Diagnostic performance of immediate colposcopy among women with high-risk human papillomavirus (HPV) other than HPV 16/18 and normal cytology
    Aydin, Serdar
    Oncu, Hande Nur
    Arici, Dilek Sema
    JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH, 2021, 47 (02) : 720 - 725
  • [4] Evaluation of HPV-16 and HPV-18 Genotyping for the Triage of Women With High-Risk HPV plus Cytology-Negative Results
    Wright, Thomas C., Jr.
    Stoler, Mark H.
    Sharma, Abha
    Zhang, Guili
    Behrens, Catherine
    Wright, Teresa L.
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2011, 136 (04) : 578 - 586
  • [5] The meaning of high-risk HPV other than type 16/18 in women with negative cytology: Is it really safe to wait for 1 year?
    Kabaca, Canan
    Giray, Burak
    Uzun, Mine Guray
    Akis, Serkan
    Purut, Yunus Emre
    Peker, Esra Keles
    Cetiner, Handan
    Ergen, Evrim Bostanci
    DIAGNOSTIC CYTOPATHOLOGY, 2021, 49 (04) : 480 - 486
  • [6] High-risk human papillomavirus, other than type 16/18, in predominantly older Taiwanese women with high-grade cervical preinvasive lesions
    Chiang, Ying-Cheng
    Cheng, Wen-Fang
    Chen, Yu-Li
    Chang, Ming-Cheng
    Hsieh, Chang-Yao
    Lin, Ming-Chieh
    Chen, Chi-An
    TAIWANESE JOURNAL OF OBSTETRICS & GYNECOLOGY, 2013, 52 (02): : 222 - 226
  • [7] Prevalence of high-grade dysplasia in cytology-negative, HPV-positive cervical cancer screening
    Stephanie M. Peace
    Ashley J. Jennings
    Archives of Gynecology and Obstetrics, 2022, 305 : 87 - 93
  • [8] Prevalence of high-grade dysplasia in cytology-negative, HPV-positive cervical cancer screening
    Peace, Stephanie M.
    Jennings, Ashley J.
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2022, 305 (01) : 87 - 93
  • [9] Comparison of biopsy results between two groups of cytology-negative HPV 16/18 and other types of high-risk HPV positive patients
    Najib, Fateme Sadat
    Hashemi, Marzieh
    Alavi, Seyed Mohammad Amin
    Shiravani, Zahra
    Jahromi, Mojgan Akbarzadeh
    Hosseini, Seyedeh Marjan
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2024, 45 (01) : 50 - 54
  • [10] The Impact of High-Risk HPV Genotypes Other Than HPV 16/18 on the Natural Course of Abnormal Cervical Cytology: A Korean HPV Cohort Study
    So, Kyeong A.
    Kim, Mi Jung
    Lee, Ki-Heon
    Lee, In-Ho
    Kim, Mi Kyung
    Lee, Yoo Kyung
    Hwang, Chang-Sun
    Jeong, Mi Seon
    Kee, Mee-Kyung
    Kang, Chun
    Cho, Chi Heum
    Kim, Seok Mo
    Hong, Sung Ran
    Kim, Ki Tae
    Lee, Won-Chul
    Park, Jong Sup
    Kim, Tae Jin
    CANCER RESEARCH AND TREATMENT, 2016, 48 (04): : 1313 - 1320